Jefferies Financial Group resumed coverage on Five Prime Therapeutics with a new price target

3/10/21 8:10:17 AM ET

Major Pharmaceuticals

Health Care

Jefferies Financial Group resumed coverage of Five Prime Therapeutics with a rating of Hold and set a new price target of $38.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$FPRX

Date	Price Target	Rating	Analyst